Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.
Tay Therapeutics has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Tay Therapeutics's investors include Scottish Enterprise, University of Dundee, O2h Ventures, Wren Capital, Meltwind Advisory.
Tay Therapeutics is headquartered in Dundee, United Kingdom.
Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.
Tay Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tay Therapeutics — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/tay-therapeutics. Accessed October 2, 2026.
VCBacked. (2021). Tay Therapeutics — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/tay-therapeutics
{{cite web |title=Tay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tay-therapeutics |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated